
Harnessing Organoid Platforms for Nanoparticle Drug Development
Introduction The advent of nanotechnology has heralded a new era in the field of cancer treatment, with nanoparticles emerging as promising candidates for improving efficacy and reducing side effects.1 Despite the promise of nanoparticles in preclinical …